Nutritional Status in the First 2 Years of Life in Cystic Fibrosis Diagnosed by Newborn Screening

J Pediatr Gastroenterol Nutr. 2018 Jul;67(1):123-130. doi: 10.1097/MPG.0000000000001956.

Abstract

Objective: To evaluate nutritional status and associated factors in a cystic fibrosis (CF) cohort diagnosed by newborn screening and followed up to month 24.

Methods: A prospective longitudinal multicenter study assessing nutritional status according to pancreatic status, feeding modalities, prescriptions, pulmonary outcome, and biological nutritional parameters.

Results: One hundred and five infants were recruited and 99 completed the study. Nutritional care management prevented undernutrition and stunting in those with exocrine pancreatic sufficiency (EPS), but affected (13/87) 15% and (21/86) 24%, respectively, of infants with exocrine pancreatic insufficiency (EPI). The logistic regression model found a positive association between both weight and length z scores "at risk" at month 24, and initial pulmonary symptoms (odds ratio [OR] 0.06, P < 0.01 and OR 0.08, P < 0.01, respectively); these symptoms were less frequent when age at first visit was earlier than 1.2 months (33% vs 67%, P = 0.02); stunting was also associated with high-calorie density intake and Staphylococcus aureus (OR 0.05, P = 0.01 and OR 0.17, P < 0.01). Pulmonary outcome did not differ according to pancreatic status; breast-feeding for at least 3 months delayed first acquisition of Pseudomonas aeruginosa. Despite sodium and fat-soluble vitamin supplementation, half of both cohorts had low urinary sodium output and half of the EPI cohort had low vitamin D levels.

Conclusions: Our data shed light on the fact that stunting was more frequent than undernutrition, while both parameters involved only patients with pancreatic insufficiency. Modalities of feeding were not associated with nutritional status; breast-feeding may provide some protection against acquisition of P aeruginosa.

Publication types

  • Multicenter Study

MeSH terms

  • Avitaminosis / drug therapy
  • Avitaminosis / etiology
  • Body Height
  • Body Weight
  • Breast Feeding
  • Carrier State / microbiology
  • Child, Preschool
  • Cystic Fibrosis / complications
  • Cystic Fibrosis / diagnosis*
  • Cystic Fibrosis / physiopathology*
  • Cystic Fibrosis / therapy
  • Enzyme Therapy
  • Exocrine Pancreatic Insufficiency / complications
  • Exocrine Pancreatic Insufficiency / physiopathology*
  • Exocrine Pancreatic Insufficiency / therapy
  • Female
  • Growth Disorders / etiology*
  • Growth Disorders / prevention & control
  • Humans
  • Infant
  • Infant, Newborn
  • Longitudinal Studies
  • Male
  • Malnutrition / etiology*
  • Malnutrition / prevention & control
  • Neonatal Screening
  • Nutritional Status*
  • Nutritional Support
  • Prospective Studies
  • Proton Pump Inhibitors / therapeutic use
  • Pseudomonas aeruginosa
  • Respiratory Tract Infections / microbiology
  • Staphylococcus aureus
  • Vitamins / therapeutic use

Substances

  • Proton Pump Inhibitors
  • Vitamins